Alberto Carlos Reino: Anticoagulation in Membranous Nephropathy – Albumin Is Not Enough
Alberto Carlos Reino, Nephrologist at Nefron SAS, shared on LinkedIn:
”Anticoagulation in Membranous Nephropathy: Albumin Is Not Enough
Yes, membranous nephropathy carries a high thrombotic risk — but serum albumin alone should not drive anticoagulation decisions.
A validated decision-analysis tool integrates both thrombotic and bleeding risk, incorporating age, kidney function, haemoglobin, bleeding history, dialysis status, and an explicit benefit–risk threshold (VTE prevented per major bleed).
This allows individualised, patient-centred decisions, rather than reflex anticoagulation.
According to KDIGO, prophylactic anticoagulation is reasonable only in patients with severe hypoalbuminemia and low bleeding risk.
Aspirin remains an option when bleeding risk is high.
Despite their popularity, DOACs remain insufficiently studied in nephrotic syndrome, where heavy proteinuria may alter both safety and efficacy.
Bottom line:
In MN, anticoagulation should be risk-stratified, evidence-based, and individualised — not protocol-driven.”
Find the Decision Analysis here.

Stay updated with Hemostasis Today.
-
Oct 7, 2026, 03:58Sohanur Rohanman Sohan: Explainable AI for Anemia Prediction Using Machine Learning
-
Oct 7, 2026, 03:00Sandeep Kumar: A Second Chance for a Child with Fanconi Anemia
-
Oct 7, 2026, 02:41Kemal Karaagac: Optimising DOAC Resumption After Major Bleeding in Atrial Fibrillation
-
Oct 7, 2026, 02:21Joseph Aslan: mPTP Inhibition Targets Platelet Procoagulant Activity and Thrombosis
-
Oct 7, 2026, 02:07Manuel Monreal: ECG Improves Risk Stratification in Acute Pulmonary Embolism
-
Oct 6, 2026, 22:43Alessandra Bosch: Pediatric GTH Opens with Regional Experts Convening on Pediatric Hemostasis and Thrombosis
-
Oct 6, 2026, 22:39Managing Thrombotic Risk in Pregnancy – How the Lab May Help – Sysmex Europe
-
Oct 6, 2026, 22:33Ahmet Davut Aksu: A Multi-Objective Approach to Enhance Fibrinolysis, Selectivity, and Inhibition Resistance
-
Oct 6, 2026, 22:29Muhammad Abubakar: New Study on Iron Biology to Be Presented at ASH 2026 and Published in Blood